Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.
Hoang
Quan V
QV
Kiernan
Daniel F
DF
Chau
Felix Y
FY
Shapiro
Michael J
MJ
Blair
Michael P
MP
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005451:Fluorescein Angiography; D005865:Gestational Age; D006801:Humans; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D007267:Injections; D017075:Laser Coagulation; D008297:Male; D012008:Recurrence; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000209:etiology* / Q000601:surgery; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab